Brain+ publishes its Annual Report 2022, highlighting important milestones and financial performance as expected
COMPANY ANNOUNCEMENT Copenhagen, Denmark, April 28, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+, a digital dementia therapeutics company, has today published its annual report for 2022, includingBusiness highlights for 2022 ·A Danish version of the company’s first product, CST - Therapist Companion was finalized for advanced market entry and the first commercial contract with a municipal dementia institution was closed. ·The development of a German version of CST - Therapist Companion was accelerated and the first of three milestones in the partnership with